Testing effectiveness (Phase 2)WithdrawnNCT02462772
What this trial is testing
Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South Africa
Who this might be right for
Human Immunodeficiency Virus
Centre for the AIDS Programme of Research in South Africa